Table 3.
ASMs tested in the apoptotic model.
| Data on Risks | Unknown Risks | |
|---|---|---|
| Higher Risks | Acetazolamide | Lorazepam |
| Clonazepam | Briviracetam | Midazolam |
| Diazepam | Cannabidiol | Oxcarbazepine |
| Phenobarbital | Cenobamate | Perampanel |
| Phenytoin | Clobazam | Pregabalin |
| Valproate | Diazepam | Primidone |
| Vigabatrin | Eslicarbazepine | Rufinamide |
| Ethosuximide | Stiripentol | |
| Lower Risks | Everolimus | Sulthiame |
| Carbamazepine | Felbamate | Tiagabine |
| Lamotrigine | Fenfluramine | Zonisamide |
| Levetiracetam | Gabapentin | |
| Topiramate | Lacosamide | |
Note that the model is predictive of effects in humans, but does not explore all possible mechanisms.
ASMs = antiseizure medications.